Roel Bogie

Chapter 3

Prevalence of patients with ≥ 1 LST in the study population Author and Year x n

Prevalence [95% CI]

Zhao (2014)

259 38050 354 52521

0.68 [0.60 , 0.77] 0.67 [0.61 , 0.75] 1.94 [1.25 , 2.88] 0.93 [0.82 , 1.05] 0.42 [0.31 , 0.54] 0.36 [0.20 , 0.61] 2.81 [1.92 , 3.96] 0.83 [0.62 , 1.07]

Reinhart (2013) Martinez (2012) Rotondano (2011)

24

1234

253 27400

Chiu (2009) Tantau (2008)

53 14

12731

3856 1104

Parra-Blanco (2006) 31

Total:

I 2 = 92.4%

0 1 2 3 4

Proportion (%)

Figure 3.4a: Forest plots showing prevalence estimates with 95% confidence intervals (Cis). | patients with one or more LSTs in the study population (x, number of LST patients; n, number of patients).

Prevalence of patients with LSTs among patients with CRNs Author and Year x n

Prevalence [95% CI] 1.99 [1.79 , 2.21] 2.71 [2.41 , 3.04] 4.53 [4.00 , 5.11] 2.35 [2.00 , 2.75] 2.22 [1.67 , 2.90] 2.43 [1.34 , 4.05] 10.40 [7.18 , 14.44] 2.97 [2.26 , 3.68]

Reinhart (2013)

354 17771 287 10595 254 5609 153 6499

Kim (2013)

Rotondano (2011)

Kim (2011) Chiu (2009) Tantau (2008)

53 14

2385

575 298

Parra-Blanco (2006) 31

Total:

I 2 = 93.9%

1.0

4.5

8 Proportion (%)

11.5

15

Figure 3.4b: Forest plots showing prevalence estimates with 95% confidence intervals (Cis). | patients with one or more LSTs among patients with colorectal neoplasms (x, number of LST patients; n, number of patients with neoplasms).

52